Nanohale AG (ETR:FYB) | Finanzwire

Basculer en Français

9475	Companies
185442	Keywords
117783	Articles
99298	Press releases

Home
Companies
Nanohale AG

BRIEF

published on 12/04/2025 at 06:35, 1 day 5 hours ago

Formycon and MS Pharma Collaborate for Keytruda® Biosimilar in MENA

MS Pharma Biosimilar Agreement Keytruda® FYB206 MENA Market Formycon Partnership
PRESS RELEASE

published on 12/04/2025 at 06:30, 1 day 5 hours ago

Formycon and MS Pharma sign exclusive commercialization partnership for Keytruda® biosimilar candidate FYB206 for the MENA Region
Formycon AG and MS Pharma enter exclusive partnership to commercialize Keytruda biosimilar FYB206 in MENA region, aiming to enhance cancer drug access

MENA Region MS Pharma Biosimilar Formycon Keytruda
BRIEF

published on 11/24/2025 at 06:35, 11 days 5 hours ago

Formycon Partners with NTC for Biosimilar Commercialization in Italy

Formycon AG Ophthalmology Biosimilar Partnerships Italy Pharmaceutical Market FYB203/Baiama®
PRESS RELEASE

published on 11/24/2025 at 06:30, 11 days 5 hours ago

NTC becomes commercialization partner for Formycon’s Eylea® biosimilar FYB203/Baiama® in Italy
Formycon AG partners with NTC for Eylea biosimilar commercialization in Italy. Agreement includes royalties and supply chain organization

Italy Formycon AG Commercialization Eylea Biosimilar NTC
BRIEF

published on 11/20/2025 at 17:05, 14 days 18 hours ago

First Berlin Reaffirms Buy Rating for Formycon AG

BUY Rating Formycon AG Revenue Guidance Dupixent Keytruda Biosimilar
PRESS RELEASE

published on 11/20/2025 at 17:00, 14 days 18 hours ago

Original-Research: Formycon AG (von First Berlin Equity Research GmbH): Buy
First Berlin Equity Research updates Buy recommendation on Formycon AG (DE000A1EWVY8) to EUR 53 target price post Q3 results surpassing expectations and upcoming FYB206 study endpoint results

First Berlin Equity Research Buy Recommendation Formycon AG FYB206 EUR 53 Target Price
BRIEF

published on 11/20/2025 at 06:35, 15 days 5 hours ago

Ranibizumab Biosimilar Epruvy® Launched in Germany

Formycon AG Ranibizumab Biosimilar Germany Launch Ophthalmic Care
PRESS RELEASE

published on 11/20/2025 at 06:30, 15 days 5 hours ago

Ranibizumab Biosimilar Epruvy® launched in Germany
Ranibizumab Biosimilar Epruvy® launched in Germany by Formycon AG, Bioeq AG, and Sandoz AG under license agreement, expanding patient access to treatment options for nAMD and retinopathies

Formycon AG Germany Ranibizumab Sandoz AG Epruvy
BRIEF

published on 11/17/2025 at 06:35, 18 days 5 hours ago

Formycon Reaches Milestone with FYB208 for Dupixent®

Biosimilars Formycon Chronic Inflammatory Diseases Dupilumab Technical Proof Of Similarity
PRESS RELEASE

published on 11/17/2025 at 06:30, 18 days 5 hours ago

Formycon achieves key development milestone with FYB208: Biosimilar candidate for Dupixent® (dupilumab) adds another growth driver to the biosimilar portfolio
Formycon achieves key development milestone with FYB208: Biosimilar candidate for Dupixent® (dupilumab) adds another growth driver to the biosimilar portfolio

Growth Biosimilar Formycon Dupixent FYB208

Accesswire

Published on 12/05/2025 at 02:35, 9 hours 8 minutes ago

Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 02:30, 9 hours 13 minutes ago

Klondike Gold Announces AGM Results
Published on 12/05/2025 at 01:00, 10 hours 43 minutes ago

BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 12 hours 38 minutes ago

BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 12 hours 43 minutes ago

NXT Energy Solutions Completes Data Acquisition for SFD Survey

View all ACCESSWIRE

EQS Group

Published on 12/05/2025 at 11:14, 28 minutes ago

Halfords Group PLC: Director/PDMR Shareholding
Published on 12/05/2025 at 10:30, 1 hour 13 minutes ago

Tradegate Exchange and Börse Berlin merge to form Tradegate BSX
Published on 12/05/2025 at 10:15, 1 hour 27 minutes ago

Wuxi’s Liangxi District: Where 3,000 Years of Jiangnan Culture Thrives
Published on 12/05/2025 at 09:40, 2 hours 2 minutes ago

Chery Partners with 2025 Asian Youth Para Games, Taking Center Stage in Global Sports with Passion and Aspiration
Published on 12/05/2025 at 09:30, 2 hours 13 minutes ago

REPLOID Group AG: Exhibitor at the BIOGAS Convention & Trade Fair in Nuremberg, Germany

Les Echos

Published on 12/05/2025 at 08:45, 2 hours 58 minutes ago

Air Liquide to expand and electrify its oxygen facility in Shaanxi, supporting China’s commitment to decarbonize its industry
Published on 12/04/2025 at 18:00, 17 hours 43 minutes ago

Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 17 hours 58 minutes ago

MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 17 hours 58 minutes ago

Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 1 day 4 hours ago

bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health

View all LES ECHOS COMFI WIRE